Search results
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal...
Brenham Banner-Press· 3 days agoOral presentation at ASCO 2024 scheduled for Monday, June 3, 2024, at 9:51 AM CDTThe abstract summary will be available on Thursday, May 23, 2024 at ~5:00pm ET
...Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20...
NBC 10 - FOX 14 Monroe· 3 days ago...a biopharmaceutical company committed to developing groundbreaking new medicines for the treatment of cancer and immunological diseases, announced today that two abstracts featuring the latest data on sunvozertinib in non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR)...
Mercy BioAnalytics to Present Results from a Large Ovarian Cancer Screening Study at the ASCO Annual...
Newswise· 3 days agoOvarian cancer is one of the leading causes of cancer death among women...
...-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical...
Digital Journal· 2 days agoTuHURA recently announced it has entered into a definitive agreement for an all-stock transaction with Kintara Therapeutics, Inc...
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO...
Morningstar· 3 days agoA copy of the ePublication...
Mercy BioAnalytics to Present Results from a Large Ovarian Cancer Screening Study at the ASCO Annual...
Morning Times· 3 days agoWALTHAM, Mass., April 24, 2024 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American
Mercy BioAnalytics to Present Results from a Large Ovarian Cancer Screening Study at the ASCO Annual...
Brenham Banner-Press· 3 days agoWALTHAM, Mass., April 24, 2024 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American
Mercy BioAnalytics to Present Results from a Large Ovarian Cancer Screening Study at the ASCO Annual...
WATE 6 Knoxville· 3 days agoMercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsy for the early detection of cancer, will present data at the 2024 American Society of Clinical Oncology (
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Char-Koosta News· 3 days agoSAN FRANCISCO and SUZHOU, China, April 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc....
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual...
Benzinga· 3 days agoREDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ((Coherus, NASDAQ:CHRS) today announced the first presentation of clinical data for CHS-114, a highly selective cytolytic anti-CCR8